ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato

ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato

Source: 
Pharmaceutical Business Review
snippet: 


Specialist HIV company ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its Dovato (dolutegravir/lamivudine) as a complete regimen to treat HIV-1 infection.